SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Elite football players 'more likely to develop dementia'
Fri March 17th - Elite male footballers are more likely to develop dementia than the general population, according to a Swedish study published today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Aspirin good for migraine

Wednesday April 14th, 2010

Aspirin may help many migraine sufferers, researchers report today.

Migraines are severe headaches which can cause nausea, vomiting and light sensitivity, and may last up to 72 hours. About 18 per cent of women and six per cent of men are regular sufferers.

The new analysis says more than half may benefit from using aspirin.

Dr Andrew Moore of the John Radcliffe Hospital, Oxford, UK, and colleagues say that many patients choose to use only over the counter medicines, but "good reviews of the evidence have been lacking". The team reviewed 13 studies involving 4,222 participants.

They found a single dose of 900-1,000mg aspirin plus 10mg of the anti-sickness drug metoclopramide "substantially reduced migraine headache pain within two hours, for more than half of people who take it".

In their Cochrane Review, they report that this treatment also reduced nausea, vomiting, and sensitivity to light or sound (photophobia or phonophobia).

This single aspirin dose reduced "moderate or severe pain" to "no pain" in 25 per cent of people, and to "mild pain" in 52 per cent, within two hours.

When taken with metoclopramide, it was particularly effective at reducing nausea and vomiting.

Side-effects were generally mild and short-lived. The combination of drugs was found to be as good as 50mg of the headache treatment sumatriptan, but not quite as effective as 100mg sumatriptan.

Dr Moore said: "Aspirin plus metoclopramide will be a reasonable therapy for acute migraine attacks, but for many it will be insufficiently effective. We are presently working on reviews of other over the counter medicines for migraines, to provide consumers with the best available evidence on treatments that don't need a prescription."

Kirthi, V. et al. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No. CD008041.

Tags: Brain & Neurology | Pain Relief | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

CATEGORIES